|
|
 |
|
Viewing report
|
|
|
|
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development
Fuji-Keizai USA, Inc., Aug 2004, Pages: 202
This report is about the market for molecular biomarkers for clinical diagnostics and for drug discovery and development. The research reviews the market segments by major diseases, by application areas, and by technologies.
This study surveyed the activities of more than 60 companies that are participating in this industry. The report analyzed the future direction of biomarkers, molecular diagnostics and pharmaco-genomic tests used in drug discovery and development.
This new report has found that the worldwide market size for molecular biomarkers, diagnostics and related molecular clinical lab services in 2003 was about $6.1 billion. The diagnostics and pharmaceutical industries each face numerous challenges that could be helped with newer business approaches that are discussed in this report. The molecular diagnostics companies are set for strong growth.
The report discusses new FDA initiatives to accelerate the approvals of diagnostics and new drugs by integrating biomarkers and pharmacogenomic tests into the drug discovery and development steps including clinical trials. The report discusses these important items with interesting and useful findings.
This study uses more than 23 figures and 47 tables to illustrate the findings. Detailed information includes several large tables about company activities, strategic alliances, technologies and so on. Twenty-three companies are profiled including details about contact information, business overview, financial details and product pipelines.
This report is available in either English or Japanese
Customers who bought this item also bought
Personalized Medicine - Scientific and Commercial Aspects
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Key Trends In Drug-diagnostic Co-Development: Identifying Collaborative Opportunities and Navigating Regulatory Challenges
The Future of Cardiovascular Diagnostics: Impact of Technological Advances on Growth Opportunities and Future Market Outlook
Licensing Strategies for Accessing Biomarker Technologies
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
Biomarkers - Advanced Technologies and Global Market (2009-2014)
Global Cancer Biomarkers Market (2010 - 2015)
Pharmacogenomics for Clinical Use and in Drug Development
In-vitro and Companion Diagnostics Industry - 2010 Yearbook
|
|
|
|
